Correlogic Systems, Inc. Product Pipeline Analysis

Publication Date	August 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	30
ISBN Number	not applicable
Product Code	GMD04723

Price

£515.00
approximately: $750 | €594

PDF

Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a Correlogic Systems, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reasons to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1.1 List Of Tables
1.2 List of Figures
2 Company Overview
2.1 Key Information
2.2 Industry Outlook In Vitro Diagnostics
3 Major Products and Services
3.1 Overview
4 Competitors
5 Key Employees
6 Locations And Subsidiaries
6.1 Head Office
7 Recent Developments
7.1 Product News
- 7.1.1 Feb 19, 2008: Quest Diagnostics To Develop Blood Test To Aid In The Detection Of Colorectal Cancer
- 7.1.2 May 15, 2005: A Serum Pattern Predictive of Breast Cancer
- 7.1.3 May 03, 2005: Development of Correlogics Prostate Cancer Blood Tests to Move Forward through Research Collaboration with the Uniformed Services University of the Health Sciences and the Henry M. Jackson Foundation for the Advancement of Military Medicine
- 7.1.4 Mar 03, 2005: A Serum Proteomic Approach to Gauging the State of Remission in Wegeners Granulomatosis
- 7.1.5 Jun 21, 2004: Correlogic Systems Ovarian Cancer Blood Test to Advance through North Shore-LIJ Research Institute Research Collaboration
- 7.1.6 Mar 03, 2004: Toxicoproteomics: Serum Proteomic Pattern Diagnostics For Early Detection Of Drug Induced Cardiac Toxicities And Cardioprotection
- 7.1.7 Nov 06, 2002: Correlogic Systems Licenses Ovarian Cancer Diagnostic Test To Quest Diagnostics and LabCorp
8 Correlogic Systems, Inc. Pipeline Products
8.1 Correlogic Systems, Inc. Product Pipeline Analysis
- 8.1.1 Correlogic Systems, Inc. Pipeline Products By Equipment Type
- 8.1.2 Correlogic Systems, Inc. Pipeline Products By Development Stage
- 8.1.3 Correlogic Systems, Inc. Pipeline Products By Therapy Area
- 8.1.4 Correlogic Systems, Inc. Pipeline Products By Clinical Trials
- 8.1.5 Correlogic Systems, Inc. Pipeline Products By News Summary
8.2 OvaCheck
- 8.2.1 Product Description
- 8.2.2 Product Status
- 8.2.3 Product Milestone
8.3 MammoCheck
- 8.3.1 Product Description
- 8.3.2 Product Status
- 8.3.3 Product Milestone
8.4 ProstaCheck
- 8.4.1 Product Description
- 8.4.2 Product Status
- 8.4.3 Clinical Trials
- 8.4.4 Product Milestone
8.5 Blood test(colorectal cancer)
- 8.5.1 Product Description
- 8.5.2 Product Status
- 8.5.3 Product Milestone
8.6 Blood test (Wegners disease)
- 8.6.1 Product Description
- 8.6.2 Product Status
- 8.6.3 Product Milestone
8.7 Experimental drug toxicity testing
- 8.7.1 Product Description
- 8.7.2 Product Status
- 8.7.3 Product Milestone
9 Appendix
9.1 Methodology
- 9.1.1 Coverage
- 9.1.2 Secondary Research
- 9.1.3 Primary Research
- 9.1.4 Expert Panel Validation
9.2 Contact Us
9.3 About Global Markets Direct
9.4 Disclaimer
1.1 List Of Tables
Table 1: Correlogic Systems, Inc.,Key Facts
Table 2: Correlogic Systems, Inc., Key Employees,
Table 3: Correlogic Systems, Inc. Pipeline Products by Equipment Type
Table 4: Correlogic Systems, Inc. Pipeline Products By Development Stage
Table 5: Correlogic Systems, Inc. Pipeline Products By Therapy Area
Table 6: Correlogic Systems, Inc. Pipeline Products By Clinical Trials
Table 7: Correlogic Systems, Inc. Pipeline Products By News Summaries
1.2 List of Figures
Figure 1: Correlogic Systems, Inc. Pipeline Products By Development Stage
Figure 2: Correlogic Systems, Inc. Pipeline Products By News Summary
Figure 3: Global Markets Direct Methodology